🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase II, single arm, unblinded study of ceritinib in patients wi...
Status
Withdrawn
Location
Duke University Medical Center
Start Date
2015-05
Trial ID
NCT02343679
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of ceritinib w...
Status
Withdrawn
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2018-01-03
Trial ID
NCT02729961
Treatments Being Tested
The rollover study will provide ceritinib to patients who are currently rec...
Status
Active Not Recruiting
Location
Highlands Oncology Group
Start Date
2015-12-11
Trial ID
NCT02584933
Treatments Being Tested
A single-arm, open-label, multicenter, phase II study. Treatment with LDK37...
Status
Completed
Location
Highlands Oncology Group Dept of Highlands Oncology Grp
Start Date
2012-11-26
Trial ID
NCT01685060
Treatments Being Tested
This National Cancer Institute (NCI)-NRG ALK Protocol phase II trial studie...
Status
Terminated
Location
CTCA at Western Regional Medical Center
Start Date
2019-07-25
Trial ID
NCT03737994
Treatments Being Tested
This is two parallel studies to examine pharmacokinetic (PK), pharmacodynam...
Status
Completed
Location
Barrow Brain and Spine
Start Date
2016-02-17
Trial ID
NCT02605746
Treatments Being Tested
A single-arm, open-label, two-stage multicenter, phase II study. Patients w...
Status
Completed
Location
Massachusetts General Hospital Mass Gen 5
Start Date
2012-12-20
Trial ID
NCT01685138
Treatments Being Tested
Primary objective: To investigate the objective response rate in patients ...
Status
Terminated
Location
National Taiwan University Hospital
Start Date
2015-03
Trial ID
NCT02374489
Treatments Being Tested
This was a single-arm, open-label, multicenter, phase II study to evaluate ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-08-21
Trial ID
NCT02450903
Treatments Being Tested
The purpose of this registration is to list Managed Access Programs (MAPs) ...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT05100134
Treatments Being Tested